Organization Profile

Related Organization(s)

You just read:

OncoGenex and Sarah Cannon Announce Completion of Patient Enrollment in the Spruce™ Clinical Trial Evaluating Apatorsen in Combination with Carboplatin and Pemetrexed in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer

News provided by

OncoGenex Pharmaceuticals, Inc.

Feb 24, 2015, 09:00 ET